Published in Z Rheumatol on October 01, 2001
Prolonged exposure to particulate pollution, genes associated with glutathione pathways, and DNA methylation in a cohort of older men. Environ Health Perspect (2011) 1.60
L1 retrotransposons in human cancers. J Biomed Biotechnol (2006) 1.34
Cartilage destruction mediated by synovial fibroblasts does not depend on proliferation in rheumatoid arthritis. Am J Pathol (2003) 1.10
Network-based gene expression biomarkers for cold and heat patterns of rheumatoid arthritis in traditional chinese medicine. Evid Based Complement Alternat Med (2012) 0.97
Time-dependent gene expression and immunohistochemical analysis of the injured anterior cruciate ligament. Bone Joint Res (2012) 0.81
Osteopontin Deficiency Suppresses Tumor Necrosis Factor-α-Induced Apoptosis in Chondrocytes. Cartilage (2012) 0.77
The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum (1990) 8.92
The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum (1990) 8.67
The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum (1990) 8.36
The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum (1990) 8.23
Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage (2005) 6.77
The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum (1990) 5.09
The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum (1990) 4.43
Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol (1996) 3.59
Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood (1980) 3.51
Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res (2000) 3.27
EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). Ann Rheum Dis (2009) 2.76
Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. Ann Rheum Dis (2007) 2.60
Synovial fibroblasts: key players in rheumatoid arthritis. Rheumatology (Oxford) (2006) 2.44
Collagen: an overview. Methods Enzymol (1982) 2.33
Preparation and use in immunohistology of antibodies specific for type I and type III collagen and procollagen. J Immunol Methods (1976) 2.28
Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models. Am J Med (1991) 2.19
Lyme borreliosis in the severe combined immunodeficiency (scid) mouse manifests predominantly in the joints, heart, and liver. Am J Pathol (1990) 2.15
HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: a potential mechanism for protease inhibitor-induced hyperlipidemia. Nat Med (2001) 2.14
[Evaluation of a German version of WOMAC (Western Ontario and McMaster Universities) Arthrosis Index]. Z Rheumatol (1996) 2.13
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis (2010) 2.09
Vitamin A-containing lipocytes and formation of type III collagen in liver injury. Proc Natl Acad Sci U S A (1976) 2.02
The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. Arthritis Rheum (1990) 2.02
Retrotransposable L1 elements expressed in rheumatoid arthritis synovial tissue: association with genomic DNA hypomethylation and influence on gene expression. Arthritis Rheum (2000) 2.01
Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction? Ann Rheum Dis (1993) 1.98
Simultaneous synthesis of types I and III collagen by fibroblasts in culture. Proc Natl Acad Sci U S A (1976) 1.97
Predictors of survival in systemic sclerosis (scleroderma). Arthritis Rheum (1991) 1.94
Comparison of the WOMAC (Western Ontario and McMaster Universities) osteoarthritis index and a self-report format of the self-administered Lequesne-Algofunctional index in patients with knee and hip osteoarthritis. Osteoarthritis Cartilage (1998) 1.93
A self-administered rheumatoid arthritis disease activity index (RADAI) for epidemiologic research. Psychometric properties and correlation with parameters of disease activity. Arthritis Rheum (1995) 1.92
Expression of osteoclast differentiation factor in rheumatoid arthritis. Arthritis Rheum (2000) 1.92
[German 2012 guidelines for the sequential medical treatment of rheumatoid arthritis. Adapted EULAR recommendations and updated treatment algorithm]. Z Rheumatol (2012) 1.91
Endoscopic ultrasound drainage of pancreatic pseudocyst: a prospective comparison with conventional endoscopic drainage. Endoscopy (2006) 1.90
Statistical approaches to classification. Methods for developing classification and other criteria rules. Arthritis Rheum (1990) 1.89
Antibodies to distinct types of collagens and procollagens and their application in immunohistology. J Immunol Methods (1977) 1.82
The collagens: an overview and update. Methods Enzymol (1987) 1.82
Pharyngeal fat in obstructive sleep apnea. Am Rev Respir Dis (1993) 1.80
Collagen content and types in the intestinal strictures of Crohn's disease. Gastroenterology (1988) 1.77
Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation. Br J Rheumatol (1997) 1.73
Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann Rheum Dis (2010) 1.73
Activation of synovial fibroblasts in rheumatoid arthritis: lack of Expression of the tumour suppressor PTEN at sites of invasive growth and destruction. Arthritis Res (2000) 1.73
Angiogenic and angiostatic factors in the molecular control of angiogenesis. Q J Nucl Med (2003) 1.71
Feasibility and validity of the RADAI, a self-administered rheumatoid arthritis disease activity index. Rheumatology (Oxford) (2000) 1.68
Recongnition by guinea-pig peritoneal exudate cells of conformationally different states of the collagen molecule. Immunology (1976) 1.55
Expression of sentrin, a novel antiapoptotic molecule, at sites of synovial invasion in rheumatoid arthritis. Arthritis Rheum (2000) 1.54
Study of differential collagen synthesis during development of the chick embryo by immunofluroescence. II. Localization of type I and type II collagen during long bone development. Dev Biol (1976) 1.53
Liver cirrhosis: immunofluorescence and biochemical studies demonstrate two types of collagen. Klin Wochenschr (1975) 1.52
Anti-tumor necrosis factor therapy and Listeria monocytogenes infection: report of two cases. Arthritis Rheum (2002) 1.51
Evaluation of latent tuberculosis infection in patients with inflammatory arthropathies before treatment with TNF-alpha blocking drugs using a novel flow-cytometric interferon-gamma release assay. Rheumatology (Oxford) (2008) 1.49
Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction. J Rheumatol (1998) 1.47
The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis. Arthritis Rheum (1990) 1.46
Overview of pathogenesis of systemic sclerosis. Rheumatology (Oxford) (2009) 1.44
The collagens of the joint. Arthritis Rheum (1980) 1.44
Assessment of resident knowledge: subjective assessment versus performance on the ACR in-training examination. Acad Radiol (1999) 1.42
Role of adipose tissue as an inflammatory organ in human diseases. Endocr Rev (2006) 1.41
Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum. Ann Rheum Dis (2006) 1.40
Low serum creatine kinase activity is associated with muscle weakness in patients with rheumatoid arthritis. J Rheumatol (1996) 1.40
Evidence of 5-lipoxygenase overexpression in the skin of patients with systemic sclerosis: a newly identified pathway to skin inflammation in systemic sclerosis. Arthritis Rheum (2001) 1.39
Analysis of the p53 tumor suppressor gene in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum (1999) 1.39
The American College of Rheumatology 1990 criteria for the classification of vasculitis. Patients and methods. Arthritis Rheum (1990) 1.38
Immunohistochemical evidence for the presence of collagen type III in human arterial walls, arterial thrombi, and in leukocytes, incubated with collagen in vitro. Klin Wochenschr (1975) 1.38
Improving protein identification from peptide mass fingerprinting through a parameterized multi-level scoring algorithm and an optimized peak detection. Electrophoresis (1999) 1.37
Expression of osteopontin messenger RNA and protein in rheumatoid arthritis: effects of osteopontin on the release of collagenase 1 from articular chondrocytes and synovial fibroblasts. Arthritis Rheum (2000) 1.36
Differential transcriptome analysis of intraarticular lesional vs intact cartilage reveals new candidate genes in osteoarthritis pathophysiology. Osteoarthritis Cartilage (2008) 1.35
The gastroenterology service: a survey of general practitioners' requirements. J R Soc Med (1993) 1.33
Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-alpha antibody: a prospective open-label pilot study. Rheumatology (Oxford) (2005) 1.33
The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology (Oxford) (2008) 1.32
The release of microparticles by apoptotic cells and their effects on macrophages. Apoptosis (2005) 1.32
Human IL-1Ra gene transfer into human synovial fibroblasts is chondroprotective. J Immunol (1997) 1.32
Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis. Hum Gene Ther (1996) 1.31
Immunohistochemical demonstration of a 44-KD phosphoprotein in developing rat bones. J Histochem Cytochem (1987) 1.30